Deepak Vangala

Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database

Mev Dominguez–Valentin, Julian R. Sampson, Toni T. Seppälä et al. · Genetics in Medicine · 2019 · 615 citations · Full text

Combined inhibition of BET family proteins and histone deacetylases as a potential epigenetics-based therapy for pancreatic ductal adenocarcinoma

Paweł K. Mazur, Alexander Herner, Stephano S. Mello et al. · Nature Medicine · 2015 · 401 citations · Full text

Histone Modifications, Chromatin, Tumor Biology +12

Blood‐based detection of <i><scp>RAS</scp></i> mutations to guide anti‐<scp>EGFR</scp> therapy in colorectal cancer patients: concordance of results from circulating tumor <scp>DNA</scp> and tissue‐based <i><scp>RAS</scp></i> testing

Wolff Schmiegel, Rodney J. Scott, S Dooley et al. · Molecular Oncology · 2017 · 159 citations · Full text

Variation in the risk of colorectal cancer in families with Lynch syndrome: a retrospective cohort study

Aung Ko Win, James G. Dowty, Jeanette C. Reece et al. · The Lancet Oncology · 2021 · 112 citations · Full text

Lynch Syndrome, Retrospective Cohort Study, Cancer Risk +10

Associations of Pathogenic Variants in MLH1, MSH2, and MSH6 With Risk of Colorectal Adenomas and Tumors and With Somatic Mutations in Patients With Lynch Syndrome

Christoph Engel, Aysel Ahadova, Toni T. Seppälä et al. · Gastroenterology · 2020 · 101 citations · Full text

Lynch Syndrome, Somatic Variant, Somatic Mutations +11